TORL BioTherapeutics
Phase 2Advancing novel antibody-based therapies to transform the lives of cancer patients.
Founded
2019
Focus
AntibodiesBiologicsSmall Molecules
About
Advancing novel antibody-based therapies to transform the lives of cancer patients.
Funding History
2Total raised: $238M
Series B$158MDeep Track CapitalDec 15, 2023
Series A$80MBlue Owl CapitalOct 15, 2021
Company Info
TypePrivate
Founded2019
LocationLos Angeles, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile